The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Background Increasing studies have shown that long noncoding RNAs (lncRNAs) are
pivotal regulators participating in carcinogenic progression and tumor metastasis in …

The liver is the most common metastatic site in colorectal cancer (CRC) patients. Indeed, 25–
30% of the cases develop colorectal liver metastasis (CLM), showing an extremely poor 5 …

Long non-coding RNAs (lncRNAs) play key roles in various malignant tumors, including
colorectal cancer (CRC). Long non-coding RNA differentiation antagonizing non-protein …

Purpose Early identification of patients at risk of developing colorectal liver metastases can
help personalizing treatment and improve oncological outcome. The aim of this study was to …

Background Glutamate dehydrogenase (GDH) is a key enzyme that catalyzes the final
reaction of the glutamine metabolic pathway, and has been reported implicated in tumor …

Long noncoding RNAs (lncRNAs) are implicated in various cancers, including colon cancer.
Liver metastasis is the main cause of colon cancer-related death. However, the roles of …

Abstract Ethnopharmacological relevance Dahuang Zhechong Pill (DZP) is a classical
formula from “Synopsis of Prescriptions of the Golden Chamber”. It has been used for …

Background lncRNAs are widely involved in multiple malignancies including colorectal
cancer (CRC). The expression and function of long intergenic non-protein coding RNA 460 …

Despite improved therapy of advanced colorectal cancer, the median overall survival (OS) is
still low. A surgical removal has significantly improved survival, if lesions are entirely …